沃尔格林联盟（WBA）股票走势 - 沃尔格林联盟（NASDAQ:WBA）的股票自2015年7月达到93美元的高点后一直处于长期下跌趋势，市值已经下跌了65%[1] 新CEO Tim Wentworth的任命 - 新CEO Tim Wentworth的任命可能会使沃尔格林联盟的情况稳定，并有望随着时间的推移改善[2] - 投资者对Wentworth的任命和他所做的决定意见不一，这在自他去年10月接任以来的总回报中反映出来（仅为+0.75%）[3] WBA的前瞻收益和成本控制 - 尽管Wentworth采取的一些措施不受欢迎，但WBA的新前瞻收益仍然在整体范围内非常有竞争力，即使减少了股息支付，仍然保持着4.5%的前瞻收益率[6] - WBA将通过减少股息支出和改善营运现金流来节省现金，有望在未来恢复以往的自由现金流水平[7][8][9][10] - Wentworth的领导下，WBA的成本基础可能会更加精简，预计在本财年内将实现约10亿美元的成本节约，这将对今年和未来两年的预期每股收益产生显著影响[12][13] 技术因素和价格走势 - 考虑到WBA的技术因素，其价格图表显示出有利的风险回报比，可能存在价格反转的迹象，相对于消费品股票组合，WBA看起来过度卖出，相对强度比率处于历史低位[14][15][16]

Walgreens Boots Alliance (WBA) closed at $22.31 in the latest trading session, marking a +1.5% move from the prior day. The stock exceeded the S&P 500, which registered a loss of 0.6% for the day. Elsewhere, the Dow saw a downswing of 0.17%, while the tech-heavy Nasdaq depreciated by 0.92%.Coming into today, shares of the largest U.S. drugstore chain had lost 2.57% in the past month. In that same time, the Retail-Wholesale sector gained 5.07%, while the S&P 500 gained 3.56%.Investors will be eagerly watchin ...

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that Chief Executive Officer, Tim Wentworth, and Global Chief Financial Officer, Manmohan Mahajan, will be presenting at the 44th Annual TD Cowen Health Care Conference, Monday, March 4 at 9:10 a.m. EST. An audio portion of the presentation will be webcast live and can be accessed through the Walgreens Boots Alliance investor relations website at https://investor.walgreensbootsalliance.com/press-releases/events-a ...

财务表现 - 华尔格林斯联盟（NASDAQ:WBA）在最近的财报中显示，其营收增长了10.0%，达到了367亿美元，超过了分析师预期[2] - 公司的调整后每股收益下降了43%，但仍高于分析师预期[2] - 公司预计未来的销售额将有所下降，但预计药房服务将超出计划[6] 成本控制和资产优化 - 公司计划在今年实现10亿美元的成本节约，并已经采取了裁员等措施[5] - 公司已经削减了股息48%，并在考虑出售一些资产以改善资产负债表[8] - 公司目前正考虑出售其专业药房业务Shields Health Solutions，以获得约40亿美元的资金[9] 估值和投资建议 - 公司的估值显示，根据2024年EBITDA的共识，WBA的EV/EBITDA倍数约为11.2倍[11] - 公司的股价在过去通常在8-15倍EBITDA之间交易，11.5倍的倍数似乎是合适的[12] - 尽管2024年仍将是一个过渡年，但公司正在为改善公司打下基础，因此继续给予该股票“买入”评级[16]

股息削减 - Walgreens Boots Alliance在一月份宣布削减股息，导致股价下跌13.6%[1] - 公司决定削减股息是为了加强资产负债表和现金状况，以便将留存现金投资于增长计划，预计将增加股东价值[2] 财务表现 - 公司在第一季度财报中显示销售额增长8.7%，但利润下降超过40%，同时在建设美国医疗保健业务方面消耗大量现金[3] 业务调整 - Walgreens正在采取多项措施以重振盈利增长和改善现金流，包括削减成本、减少资本支出和改善营运资本[4]

公司管理变动 - Walgreens Boots Alliance首席执行官Tim Wentworth将临时首席财务官职位永久化，并任命了公司不断增长的医疗业务的新负责人[1] - Wentworth正在努力扭转这家标志性药店连锁企业的局面，任命了三名新的高管[5] 股权变动 - 公司减持了药品分销商Cencora的股份，价值992亿美元，用于偿还债务和一般公司用途[3]

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance (Nasdaq: WBA) Chief Executive Officer Tim Wentworth today announced updates to WBA’s Executive Committee as the company advances a health services strategy rooted in its retail pharmacy footprint. “Today’s announcement solidifies the leadership team that will carry WBA into its future as we look to expand our reach beyond neighborhood pharmacies into the fastest-growing areas of healthcare,” said Wentworth. “We have a strong team with a track rec ...

Walgreens Boots Alliance (WBA) closed the latest trading day at $22.81, indicating a -1.3% change from the previous session's end. This move lagged the S&P 500's daily gain of 0.82%. Meanwhile, the Dow experienced a rise of 0.41%, and the technology-dominated Nasdaq saw an increase of 0.95%.Coming into today, shares of the largest U.S. drugstore chain had lost 8.87% in the past month. In that same time, the Retail-Wholesale sector gained 7.3%, while the S&P 500 gained 5.59%.Market participants will be close ...

Bloomberg/Bloomberg via Getty Images Investment Thesis I last covered the ProShares S&P 500 Dividend Aristocrats ETF (BATS:NOBL) in December, reasoning that its stronger dividend metrics made it a better Dividend Aristocrats choice over KNGZ, which recently changed strategies. Still, the evidence indicates that its 25 years of consecutive dividend increases screen is insufficient to keep poor-quality stocks out, limiting its total return potential. Despite free cash flow margins stuck between 0-5% and t ...

药学院长咨询委员会成立 - Walgreens通过成立Walgreens院长咨询委员会来加强与药学院的关系，以提升药学专业并更好地支持药剂师[1] 药学行业挑战 - 目前药学行业面临着明显的劳动力短缺，药学院的申请人数下降，需要改变药剂师的工作模式[3] 委员会目标 - 委员会的首要目标包括重建人才储备、提升社区药房作为首选实践场所、解决员工挑战、推动药剂师实践服务[4]